Altered microRNA and gene expression in the follicular fluid of women with polycystic ovary syndrome

Journal of Assisted Reproduction and Genetics

Volumn 31, Issue 3, 2014, Pages 355-362

  Roth, Lauren W ^a   McCallie, Blair ^b   Alvero, Ruben ^a   Schoolcraft, William B ^c   Minjarez, Debra ^c   Katz Jaffe, Mandy G ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b National Foundation for Fertility Research   (United States)

^c Colorado Center for Reproductive Medicine ^*  (United States)

Author keywords

Follicular fluid; microRNAs; Oocyte donors; Polycystic ovary syndrome

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; MICRORNA; MICRORNA 138; MICRORNA 142; MICRORNA 18B; MICRORNA 32; MICRORNA 34C; MICRORNA 489; MICRORNA 627; MICRORNA 888; MICRORNA 9; MUELLERIAN INHIBITING FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENE EXPRESSION; HUMAN; HUMAN TISSUE; OOCYTE DONATION; OOCYTE RETRIEVAL; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR FLUID; GENE EXPRESSION REGULATION; GRANULOSA CELLS; HUMANS; MICRORNAS; OOCYTES; POLYCYSTIC OVARY SYNDROME;

EID: 84896103242     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-013-0161-4     Document Type: Article

References (39)

1. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R. Fertil Steril. 2012;97(1):28-38. doi:10.1016/j.fertnstert.2011.09.024. e25.
2. Health and fertility in World Health Organization group 2 anovulatory women. Hum Reprod Update. 2012;18(5):586-99. doi:10.1093/humupd/dms019.
3. Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012. doi:10.1093/humrep/des232.
4. Koivunen R, Pouta A, Franks S, Martikainen H, Sovio U, Hartikainen AL, et al. Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. Hum Reprod. 2008;23(9):2134-9. doi:10.1093/humrep/den136.
5. Sang Q, Yao Z, Wang H, Feng R, Zhao X, Xing Q, et al. Identification of microRNAs in human follicular fluid: characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo. J Clin Endocrinol Metab. 2013. doi:10.1210/jc.2013-1715.
6. Ambros V. microRNAs: tiny regulators with great potential. Cell. 2001;107(7):823-6. (Pubitemid 34084973)
7. McCallie B, Schoolcraft WB, Katz-Jaffe MG. Aberration of blastocyst microRNA expression is associated with human infertility. Fertil Steril. 2010;93(7):2374-82. doi:10.1016/j.fertnstert.2009.01.069.
8. Barbarotto E, Schmittgen TD, Calin GA. MicroRNAs and cancer: profile, profile, profile. Int J Cancer. 2008;122(5):969-77. doi:10.1002/ijc.23343. (Pubitemid 351213993)
9. Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M, et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol. 2007;42(6):1137-41. doi:10.1016/j.yjmcc.2007. 04.004. (Pubitemid 46829201)
10. Hawkins SM, Creighton CJ, Han DY, Zariff A, Anderson ML, Gunaratne PH, et al. Functional microRNA involved in endometriosis. Mol Endocrinol. 2011;25(5):821-32. doi:10.1210/me.2010-0371.
11. Wang C, Yang C, Chen X, Yao B, Zhu C, Li L, et al. Altered profile of seminal plasma microRNAs in the molecular diagnosis of male infertility. Clin Chem. 2011;57(12):1722-31. doi:10.1373/clinchem.2011.169714.
12. Osman A. MicroRNAs in health and disease-basic science and clinical applications. Clin Lab. 2012;58(5-6):393-402.
13. da Silveira JC, Veeramachaneni DN, Winger QA, Carnevale EM, Bouma GJ. cell-secreted vesicles in equine ovarian follicular fluid contain miRNAs and proteins: a possible new form of cell communication within the ovarian follicle. Biol Reprod. 2012;86(3):71. doi:10.1095/biolreprod.111.093252.
14. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56(11):1733-41. doi:10.1373/clinchem.2010.147405.
15. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105(30):10513-8. doi:10.1073/pnas. 0804549105.
16. Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One. 2012;7(3):e30679. doi:10.1371/journal.pone.0030679.
17. Ajit SK. Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors (Basel). 2012;12(3):3359-69. doi:10.3390/ s120303359.
18. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M, et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet. 2011;4(4):446 - 54. doi:10.1161/circgenetics.110.958975.
19. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, Guo H, et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem. 2010;56(12):1830-8. doi:10.1373/clinchem.2010.147850.
20. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30(9):e36.
21. Burks DJ. Font de Mora J, Schubert M, Withers DJ, Myers MG, Towery HH et al. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature. 2000;407(6802):377-82.
22. Runesson E, Ivarsson K, Janson PO, Brannstrom M. Gonadotropin-and cytokine-regulated expression of the chemokine interleukin 8 in the human preovulatory follicle of the menstrual cycle. J Clin Endocrinol Metab. 2000;85(11):4387-95. (Pubitemid 32055403)
23. Zhou Y, Zhu Y, Zhang S, Wang H, Wang S, Yang X. MicroRNA expression profiles in premature ovarian failure patients and its potential regulate functions. Chinese journal of birth health and heredity. 2011;19:20-2.
24. Neganova I, Al-Qassab H, Heffron H, Selman C, Choudhury AI, Lingard SJ, et al. Role of central nervous system and ovarian insulin receptor substrate 2 signaling in female reproductive function in the mouse. Biol Reprod. 2007;76(6):1045-53. doi:10.1095/biolreprod.106.059360. (Pubitemid 46835013)
25. 2+-triggered exocytosis. Biochem J. 2002;366(Pt 1):1 - 13. doi:10.1042/bj20020776.
26. Lang J, Fukuda M, Zhang H, Mikoshiba K, Wollheim CB. The first C2 domain of synaptotagmin is required for exocytosis of insulin from pancreatic beta-cells: action of synaptotagmin at low micromolar calcium. EMBO J. 1997;16(19):5837-46. doi:10.1093/emboj/16.19.5837. (Pubitemid 27427280)
27. Nakajima-Nagata N, Sugai M, Sakurai T, Miyazaki J, Tabata Y, Shimizu A. Pdx-1 enables insulin secretion by regulating synaptotagmin 1 gene expression. Biochem Biophys Res Commun. 2004;318(3):631-5. doi:10.1016/j.bbrc.2004.04.071. (Pubitemid 38624200)
28. Nyhlen K, Gautam C, Andersson R, Srinivas U. Modulation of cytokine-induced production of IL-8 in vitro by interferons and glucocorticosteroids. Inflammation. 2004;28(2):77-88. (Pubitemid 38932384)
29. Shimizu T, Kaji A, Murayama C, Magata F, Shirasuna K, Wakamiya K, et al. Effects of interleukin-8 on estradiol and progesterone production by bovine granulosa cells from large follicles and progesterone production by luteinizing granulosa cells in culture. Cytokine. 2012;57(1):175-81. doi:10.1016/j.cyto. 2011.11.007.
30. Donadeu FX, Schauer SN, Sontakke SD. Involvement of miRNAs in ovarian follicular and luteal development. J Endocrinol. 2012;215(3):323-34. doi:10.1530/joe-12-0252.
31. Berezikov E. Evolution of microRNA diversity and regulation in animals. Nat Rev Genet. 2011;12(12):846-60. doi:10.1038/nrg3079.
32. DA Zawadski JK. Diagnostic for polycystic ovary syndrome: Towards a rational approach. Polycystic Ovary Syndrome (Current Issues in Endocrinology and Metabolism). Boston: Blackwell Scientific Inc.; 1992.
33. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456 - 88. doi:10.1016/j.fertnstert.2008.06.035.
34. Abbott DH, Bacha F. Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood. Fertil Steril. 2013;100(1):2-11. doi:10.1016/j.fertnstert.2013.05.023.
35. Srivastava A, Goldberger H, Dimtchev A, Ramalinga M, Chijioke J, Marian C, et al. MicroRNA Profiling in Prostate Cancer - The Diagnostic Potential of Urinary miR-205 and miR-214. PLoS One. 2013;8(10):e76994. doi:10.1371/journal. pone.0076994.
36. Roncarati R, Anselmi CV, Losi MA, Papa L, Cavarretta E, Costa Martins PD, et al. Circulating miR-29a, Among Other Upregulated microRNAs, is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients with Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2013. doi:10.1016/j.jacc.2013.09.041.
37. Aguado-Fraile E, Ramos E, Conde E, Rodriguez M, Liano F, Garcia-Bermejo ML. microRNAs in the kidney: Novel biomarkers of Acute Kidney Injury. Nefrologia. 2013. doi:10.3265/Nefrologia.pre2013. Aug.12198.
38. Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T. MicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease. J Alzheimers Dis. 2013. doi:10.3233/jad-130932.
39. Chen YH, Heneidi S, Lee JM, Layman LC, Stepp DW, Gamboa GM, et al. miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes. 2013;62(7):2278-86. doi:10.2337/db12-0963.